Cargando…
Impact of Monthly Prescription Cap on Medication Persistence Among Patients with Hypertension, Hyperlipidemia, or Diabetes
BACKGROUND: Hypertension, hyperlipidemia, and diabetes are among the most prevalent and costly chronic health conditions affecting the U.S. population. Prescription treatments for these conditions are of critical importance to the health of patients, yet suboptimal adherence to prescription treatmen...
Autores principales: | Wang, Chi-Chuan, Wei, David, Farley, Joel F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437688/ https://www.ncbi.nlm.nih.gov/pubmed/23537460 http://dx.doi.org/10.18553/jmcp.2013.19.3.258 |
Ejemplares similares
-
Alterations of Urinary Microbiota in Type 2 Diabetes Mellitus with Hypertension and/or Hyperlipidemia
por: Liu, Fengping, et al.
Publicado: (2017) -
Validation of the diabetes, hypertension and hyperlipidemia (DHL) knowledge instrument in Malaysia
por: Lai, Pauline SM, et al.
Publicado: (2012) -
Accuracy of Self-Reported Hypertension, Diabetes, and Hyperlipidemia among Adults of Liwan, Guangzhou, China
por: GUO, Huijie, et al.
Publicado: (2020) -
Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia
por: Cybulsky, Marta, et al.
Publicado: (2016) -
Comparative Effectiveness of Guidelines for the Management of Hyperlipidemia and Hypertension for Type 2 Diabetes Patients
por: Shah, Nilay D., et al.
Publicado: (2011)